In addition, a recent study showed that patients affected by prostate cancer and treated with radical prostatectomy displayed a significant correlation with a higher risk of recurrence in the absence of PTEN protein (assessed by immunohistochemistry (IHC) analysis) expression [76]. This evidence concerns the gene PTEN and prostate carcinoma.